Back
Monster Beverage 10K Form
Buy
52
MNST
Monster Beverage
Last Price:
54.0700
Seasonality Move:
3.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | MNST/Monster Beverage Quarterly |
2023-11-06 | 10Q | MNST/Monster Beverage Quarterly |
2023-08-04 | 10Q | MNST/Monster Beverage Quarterly |
2023-05-05 | 10Q | MNST/Monster Beverage Quarterly |
2022-11-04 | 10Q | MNST/Monster Beverage Quarterly |
2022-08-05 | 10Q | MNST/Monster Beverage Quarterly |
Receive MNST News And Ratings
See the #1 stock for the next 7 days that we like better than MNST
MNST Financial Statistics
Sales & Book Value
Annual Sales: | $7.14B |
---|---|
Cash Flow: | $556.31M |
Price / Cash Flow: | 35.02 |
Annual Sales: | $5.94 |
Price / Book: | 9.1 |
Profitability
EPS (TTM): | 1.56000 |
---|---|
Net Income (TTM): | $1.61B |
Gross Margin: | $3.79B |
Return on Equity: | 22.1% |
Return on Assets: | 17.75% |
Monster Beverage Earnings Forecast
Key Monster Beverage Financial Ratios
- The Gross Profit Margin over the past 32 years for MNST is 53.14%.
- The Selling, General & Administrative Expenses for MNST have been equal to 0.00% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of MNST is 22.84% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 25 years.
Monster Beverage Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Beverages |
Sector: | Consumer Staples |
Current Symbol: | MNST |
CUSIP: | 61174X |
Website: | monsterbevcorp.com |
Debt
Debt-to-Equity Ratio: | 0.13 |
---|---|
Current Ratio: | 3.13 |
Quick Ratio: | 2.34 |
Price-to-Earnings
Trailing P/E Ratio: | 35.1 |
---|---|
Forward P/E Ratio: | 28.78 |
MNST Technical Analysis vs Fundamental Analysis
Buy
52
Monster Beverage (MNST)
is a Buy
Is Monster Beverage a Buy or a Sell?
-
Monster Beverage stock is rated a Buy
The current Monster Beverage [MNST] share price is $54.0600. The Score for MNST is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.